Matrix metalloproteinase-2 and -9 levels in patients with dilated ascending aorta and bicuspid aortic valve

Echocardiography

Volumn 30, Issue 2, 2013, Pages 121-126

  Abaci, Okay ^a   Kocas, Cuneyt ^a   Kilickesmez, Kadriye Orta ^a   Uner, Sinan ^a   Kucukoglu, Serdar ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

aorta; bicuspid aortic valve; matrix metalloproteinases

Indexed keywords

GELATINASE A; GELATINASE B;

ADULT; AORTA; AORTA ARCH; AORTA DISEASE; AORTA ROOT; ARTERY DILATATION; ARTICLE; ASCENDING AORTA; ASCENDING AORTA DILATATION; BICUSPID AORTIC VALVE; BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; BODY SURFACE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RATE; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; AORTA; AORTIC DISEASES; AORTIC VALVE; DIAGNOSIS, DIFFERENTIAL; DILATATION, PATHOLOGIC; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RETROSPECTIVE STUDIES;

EID: 84873719882     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/echo.12004     Document Type: Article

References (35)

1. Larson EW, Edwards WD,: Risk factors for aortic dissection: A necropsy study of 161 cases. Am J Cardiol 1984; 53: 849-855.
2. Gray GW, Salisbury DA, Gulino AM,: Echocardiographic and color flow Doppler findings in military pilot applicants. Aviat Space Environ Med 1995; 66: 32-34.
3. Fedak PW, Verna S, David TE, et al. Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation 2002; 106: 900-904.
4. Braverman AC,: Bicuspid aortic valve and associated aortic wall abnormalities. Curr Opin Cardiol 1996; 11: 501-503.
5. Keane MG, Wiegers SE, Plappert T, et al. Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvuler lesions. Circulation 2000; 102: III35-III39.
6. Roberts WC,: The congenitally bicuspid aortic valve. A study of 85 autopsy cases. Am J Cardiol 1970; 26: 72-83.
7. de Sa M, Moshkovitz Y, Butany J, et al. Histologic abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aortic valve disease: Clinical relevance to the ross procedure. J Thorac Cardiovasc Surg 1999; 118: 588-594.
8. Parai JL, Masters RG, Walley VM, et al. Aortic medial changes associated with bicuspid aortic valve: Myth or reality? Can J Cardiol 1999; 15: 1233-1238.
9. Busuttil RW, Rinderbriecht H, Flesher A, et al. Elastase activity: The role of elastase in aortic aneurysm formation. J Surg Res 1982; 32: 214-217.
10. Fedak PW, de Sa MP, Verma S, et al. Vascular matrix remodeling in patients with bicuspid aortic valve malformations: İmplications for aortic dilatation. J Thorac Cardiovasc Surg 2003; 126: 797-806.
11. Nistri S, Sorbo MD, Basso C, et al. Bicuspid aortic valve: Abnormal aortic elastic properties. J Heart Valve Dis 2002; 11: 369-373.
12. Twining SS,: Regulation of proteolytic activity in tissues. Crit Rev Biochem Mol Biol 1994; 29: 315-383.
13. Visse R, Nagase H,: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 2003; 92: 827-839.
14. Longo GM, Xiong W, Greiner TC, et al. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002; 110: 625-632.
15. Roman MJ, Devereux RB, Kramer-Fox R, et al. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol 1989; 64: 507-512.
16. Schaefer BM, Lewin MB, Stout KK, et al. The bicuspid aortic valve: An integrated phenotypic classification of leaflet morphology and aortic root shape. Heart 2008; 94: 1634-1638.
17. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
18. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. American Society of Echocardiography: Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777-802.
19. Bader H,: Dependence of wall stress in the human thoracic aorta on age and pressure. Circ Res 1967; 20: 354-361.
20. Cecconi M, Manfrin M, Moraca A, et al. Aortic dimensions in patients with bicuspid aortic valve without significant valve dysfunction. Am J Cardiol 2005; 95: 292-294.
21. Gurvitz M, Chang RK, Drant S, et al. Frequency of aortic root dilation in children with a bicuspid aortic valve. Am J Cardiol 2004; 94: 1337-1340.
22. Braverman AC, Güven H, Beardslee MA, et al. The bicuspid aortic valve. Curr Probl Cardiol 2005; 30: 470-522.
23. Basso C, Boschello M, Perrone C, et al. An echocardiographic survey of primary school children for bicuspid aortic valve. Am J Cardiol 2004; 93: 661-663.
24. Jassal DS, Bhagirath KM, Tam JW, et al. Association of Bicuspid aortic valve morphology and aortic root dimensions: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study. Echocardiography 2010; 27: 174-179.
25. Aboulhosn J, Child JS,: Left ventricular outflow obstruction: Subaortic stenosis, bicuspid aortic valve, supravalvar aortic stenosis, and coarctation of the aorta. Circulation 2006; 114: 2412-2422.
26. Golledge J, Tsao PS, Dalman RL, et al. Circulating markers of abdominal aortic aneurysm presence and progression. Circulation 2008; 118: 2382-2392.
27. Parks WC,: A confederacy of proteinases. J Clin Invest 2002; 110: 613-614.
28. Dollery CM, McEwan JR, Henney AM,: Matrix metalloproteinases and cardiovascular disease. Circ Res 1995; 77: 863-868.
29. McMillan WD, Pearce WH,: Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg 1999; 29: 122-127.
30. Boyum J, Fellinger EK, Schmoker JD, et al. Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves. J Thorac Cardiovasc Surg 2004; 127: 686-691.
31. Phillippi JA, Klyachko EA, Kenny JP, et al. Gleason basal and oxidative stress-nduced expression of metallothionein s decreased. Circulation 2009; 119: 2498-2506.
32. Wilton E, Bland M, Thompson M, et al. Matrix metalloproteinase expression in the ascending aorta and aortic valve. Interact Cardiovasc Thorac Surg 2008; 7: 37-40.
33. Tzemos N, Lyseggen E, Silversides C, et al. Endothelial function, carotid-femoral stiffness, and plasma matrix metalloproteinase-2 in men with bicuspid aortic valve and dilated aorta. J Am Coll Cardiol 2010; 7: 660-668.
34. Cripe L, Andelfinger G, Martin LJ, et al. Bicuspid aortic valve is heritable. J Am Coll Cardiol 2004; 44: 138-143.
35. Robicsek F, Thubrikar MJ, Cook JW, et al. The congenitally bicuspid aortic valve: How does it function? Why does it fail? Ann Thorac Surg 2004; 77: 177-185.